How Parkinson Disease Medications Work

Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain. Dopamine plays a crucial role in regulating movement, and its deficiency leads to the hallmark symptoms of Parkinson's: bradykinesia (slow movement), resting tremor, rigidity, and postural instability.

Gold Standard Treatment: Levodopa

The gold standard treatment for Parkinson's disease is Levodopa, a dopamine replacement therapy. Levodopa works by crossing the blood-brain barrier and being converted into dopamine in the brain, thereby replenishing the depleted dopamine stores. This leads to an improvement in motor symptoms.

Alternatives to Levodopa

• Dopamine Agonists: These medications mimic the action of dopamine in the brain and are used as an alternative to Levodopa. They include non-ergoline dopamine agonists such as pramipexole and ropinirole.

• COMT Inhibitors: Catechol-O-Methyltransferase (COMT) inhibitors, such as entacapone, work by preventing the breakdown of Levodopa in the brain, thereby increasing its availability and effectiveness.

• MAO-B Inhibitors: Monoamine oxidase B (MAO-B) inhibitors, such as selegiline, prevent the breakdown of dopamine in the brain, leading to an increase in dopamine levels and improved motor symptoms.

Key Considerations

When choosing a medication for Parkinson's disease, it is essential to consider individual patient factors, including age, medical history, and response to previous treatments. Regular monitoring of motor symptoms and potential side effects is crucial to optimize treatment outcomes.